Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control.

Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 08 11 2023
revised: 21 03 2024
accepted: 07 04 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

Avian influenza virus continues to pose zoonotic, epizootic, and pandemic threats worldwide, as exemplified by the 2020-23 epizootics of re-emerging H5 genotype avian influenza viruses among birds and mammals and the fatal jump to humans of emerging A(H3N8) in early 2023. Future influenza pandemic threats are driven by extensive mutations and reassortments of avian influenza viruses rooted in frequent interspecies transmission and genetic mixing and underscore the urgent need for more effective actions. We examine the changing global epidemiology of human infections caused by avian influenza viruses over the past decade, including dramatic increases in both the number of reported infections in humans and the spectrum of avian influenza virus subtypes that have jumped to humans. We also discuss the use of advanced surveillance, diagnostic technologies, and state-of-the-art analysis methods for tracking emerging avian influenza viruses. We outline an avian influenza virus-specific application of the One Health approach, integrating enhanced surveillance, tightened biosecurity, targeted vaccination, timely precautions, and timely clinical management, and fostering global collaboration to control the threats of avian influenza viruses.

Identifiants

DOI: 10.1016/S1473-3099(24)00234-2 PMID: 38878787
pubmed: 38878787
pii: S1473-3099(24)00234-2
doi: 10.1016/S1473-3099(24)00234-2
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.

Déclaration de conflit d'intérêts

Declaration of interests MAS receives grants from the US National Institutes of Health within the scope of this work and grants and contracts from the US Department of Veterans Affairs, US Food and Drug Administration, and Janssen Research and Development outside the scope of this work. All other authors declare no competing interests.

Auteurs

Mei Kang (M)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China; Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Li-Fang Wang (LF)

National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Bo-Wen Sun (BW)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Wen-Bo Wan (WB)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Xiang Ji (X)

Department of Mathematics, School of Science and Engineering, Tulane University, New Orleans, LA, USA.

Guy Baele (G)

Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, Leuven, Belgium.

Yu-Hai Bi (YH)

CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Marc A Suchard (MA)

Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA; Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.

Alexander Lai (A)

School of Science, Technology, Engineering, and Mathematics, Kentucky State University, Frankfort, KY, USA.

Min Zhang (M)

Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Lin Wang (L)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yan-Hong Zhu (YH)

Department of Scientific Research Management, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Lei Ma (L)

Department of Scientific Research Management, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Hai-Peng Li (HP)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Ayidana Haerheng (A)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Yang-Rui Qi (YR)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Rui-Lan Wang (RL)

Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Na He (N)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.

Shuo Su (S)

Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China. Electronic address: shuosu@fudan.edu.cn.

Classifications MeSH